YBX1 and hereditary clear cell renal cell carcinoma: Similarly, another study showed increased YBX1 expression in 32 renal cell carcinoma (RCC) patients, and the genetic ablation of YBX1 in vitro was shown to inhibit the phosphorylation of NF-κB on S536.